Over the past few years, many people worldwide have been affected by Lyme disease, which has created a huge and imperative need for Lyme disease diagnostic market. A new report “
Global Lyme Disease Diagnostic Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast” offered by DecisionDatabases.com gives an analytical study of the market, its value chain, latest trends, forecasts, innovation, drivers, and restraints. The historical study from 2015 helps in a better understanding of the market. The report also details about the
lyme disease diagnostic market players who hold a dominating position in the global business scenario.
Lyme disease is a communicable disease caused by a bacteria “Borrelia burgdorferi”. It is transmitted by the bite of infected blacklegged ticks to humans. If this disease is not treated and diagnosed on time, then it can cause death, affect CNS and other key organs failure in the patient. The diagnostics can help in providing a proper course of action by physicians for the treatment of the patient. Rising incidences of the disease, especially in North America is a major driver, which is expected to fuel market demand in the region over the coming years. However, inefficiency in the procedure of the disease diagnostic is a key concern, which can restrict the market growth in the near future.
The global market has been segmented based on the diagnostic test into serological test, urine antigen tests, lymphocytic transformation test, immunofluorescent staining and PCR tests. The serological test is the widely used diagnostic tests and this segment is expected to witness a double-digit growth in the study period owing to its growing demand as a primary verification test for the diagnosis of Lyme disease across the globe. The market has been further segmented based on emerging technologies into molecular diagnostics, monoclonal antibodies, immunoassays, differential light scattering, liposomes, artificial intelligence, flow cytometry, information technology, diagnostic imaging, gel microdroplets and chromatography. Furthermore, the market has been segmented on the basis of end-user.
North America is a major market and is projected to continue its dominance during the forecast period on account of rising occurrence of common tick disease along with high demand for effective disease treatment in the region. The European and Asian markets are also anticipated to emerge as a growing market in the future due to increase in the number of infected patients.
The industry players holding the dominant share of the industry include Abbott Laboratories, Canon U.SLife Sciences, T2 Biosystems, Bio-Rad Laboratories, Alere Inc (ALR), Roche Diagnostics International Ltd., Graphene Frontiers, Covance Inc., Boulder Diagnostics, Immunetics Inc., GlaxoSmithKline Pharmaceuticals Ltd., Affymetrix Inc., Siemens AG, Baxter International Inc., and Fresenius Medical Care AG & Co.
In Nov 2012, Boulder Diagnostics Inc. has launched “SpiroFind” Lyme Disease Diagnostic Test for the detection of active Borreliosis.
In April 2016, LymeDisease.org has introduced an interactive Lyme Disease Symptom Checklist which can help the patient in early diagnosis of Lyme disease.
About-Us:
DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics. DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.
Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors. We provide intellectual, precise and meaningful data at a lightning speed.
For more details:
DecisionDatabases.com
E-Mail:
[email protected]
Phone: +91 99 28 237112
Web: www.decisiondatabases.com/
